Cargando…
Paricalcitol Reduces Peritoneal Fibrosis in Mice through the Activation of Regulatory T Cells and Reduction in IL-17 Production
Fibrosis is a significant health problem associated with a chronic inflammatory reaction. The precise mechanisms involved in the fibrotic process are still poorly understood. However, given that inflammation is a major causative factor, immunomodulation is a possible therapeutic approach to reduce f...
Autores principales: | González-Mateo, Guadalupe T., Fernández-Míllara, Vanessa, Bellón, Teresa, Liappas, Georgios, Ruiz-Ortega, Marta, López-Cabrera, Manuel, Selgas, Rafael, Aroeira, Luiz S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184804/ https://www.ncbi.nlm.nih.gov/pubmed/25279459 http://dx.doi.org/10.1371/journal.pone.0108477 |
Ejemplares similares
-
T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage
por: Liappas, Georgios, et al.
Publicado: (2015) -
Corrigendum to “T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage”
por: Liappas, Georgios, et al.
Publicado: (2017) -
Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis
por: Loureiro, Jesús, et al.
Publicado: (2013) -
TWEAK Promotes Peritoneal Inflammation
por: Sanz, Ana Belen, et al.
Publicado: (2014) -
Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis
por: Stavenuiter, Andrea W. D., et al.
Publicado: (2015)